SEC Form 4 · accession 0001209191-17-052898
MAGELLAN HEALTH INC · MGLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mostafa Kamal
Officer — CEO, Magellan Rx Management
Period of report
Sep 12, 2017
Accepted (ET)
Sep 14, 2017 · 9:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000019411
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Common Stock, $0.01 par value | Sep 12, 2017 | X | 19 | $60.55 | A | 19 | D | |
| Ordinary Common Stock, $0.01 par value | Sep 12, 2017 | S | 19 | $83.00 | D | 0 | D | |
| Ordinary Common Stock, $0.01 par value | Sep 13, 2017 | X | 585 | $60.55 | A | 585 | D | |
| Ordinary Common Stock, $0.01 par value | Sep 13, 2017 | S | 585 | $83.00 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3,F2 | $60.55 | Sep 12, 2017 | X | 19 | D | — | Aug 3, 2025 | Common Stock | 19 | 41,011 | D |
| Stock Option (right to Buy)F3,F2 | $60.55 | Sep 13, 2017 | X | 585 | D | — | Aug 3, 2025 | Common Stock | 585 | 40,426 | D |
Explanation of responses
- F1This transaction was effectuated pursuant to a Rule 10b-5-1 Plan.
- F2Of the 40,426 stock options remaining in this tranche, 23,760 are currently vested and available. The remainder of 16,667 options shall vest on August 3, 2018.
- F3Not applicable.